141 related articles for article (PubMed ID: 3909331)
21. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria.
Cox CE
Rev Infect Dis; 1985; 7 Suppl 4():S767-71. PubMed ID: 3909335
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with aztreonam in the treatment of gram-negative bacteremia.
Scully BE; Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S789-93. PubMed ID: 3909338
[TBL] [Abstract][Full Text] [Related]
23. The use of aztreonam in the cystic fibrosis patient.
Matsen JM; Bosso JA
Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S117-9; discussion S128-32. PubMed ID: 2682510
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.
Rodríguez JR; Ramírez-Ronda CH; Nevárez M
Antimicrob Agents Chemother; 1985 Feb; 27(2):246-51. PubMed ID: 4039118
[TBL] [Abstract][Full Text] [Related]
25. Monobactams and carbapenems for treatment of intraabdominal infections.
Brismar B; Nord CE
Infection; 1999; 27(2):136-47. PubMed ID: 10219648
[TBL] [Abstract][Full Text] [Related]
26. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
Rodriguez JR; Ramirez-Ronda CH
Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
Norrby SR
Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788
[TBL] [Abstract][Full Text] [Related]
29. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
30. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
32. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
33. Treatment of gram-negative infections with aztreonam.
Simons WJ; Lee TJ
Am J Med; 1985 Feb; 78(2A):27-30. PubMed ID: 4038577
[TBL] [Abstract][Full Text] [Related]
34. Aztreonam activity, pharmacology, and clinical uses.
Neu HC
Am J Med; 1990 Mar; 88(3C):2S-6S; discussion 38S-42S. PubMed ID: 2180293
[TBL] [Abstract][Full Text] [Related]
35. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
36. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
37. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
[TBL] [Abstract][Full Text] [Related]
38. [Aztreonam versus tobramycin in acute pyelonephritis. A comparative study].
Gallego J; Jiménez Cruz JF; Gobernado M; Llopis B; Vidal J; Server G; Ruiz JL; David Vera C
Arch Esp Urol; 1989 Mar; 42(2):116-9. PubMed ID: 2660754
[TBL] [Abstract][Full Text] [Related]
39. The use of aztreonam in pediatric patients: a review.
Bosso JA; Black PG
Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
[TBL] [Abstract][Full Text] [Related]
40. Aztreonam in the treatment of gram-negative bacterial meningitis.
Lentnek AL; Williams RR
Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
